Literature DB >> 21691307

Therapy: HIV-associated dyslipidemia: the heart positive study.

Steven Grinspoon1, Kathleen Fitch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691307     DOI: 10.1038/nrendo.2011.109

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia.

Authors:  Colleen Hadigan; James Liebau; Martin Torriani; Rebecca Andersen; Steven Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2006-08-29       Impact factor: 5.958

Review 3.  Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

Authors:  Steven Grinspoon; Andrew Carr
Journal:  N Engl J Med       Date:  2005-01-06       Impact factor: 91.245

Review 4.  Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.

Authors:  Michael P Dubé; James H Stein; Judith A Aberg; Carl J Fichtenbaum; John G Gerber; Karen T Tashima; W Keith Henry; Judith S Currier; Dennis Sprecher; Marshall J Glesby
Journal:  Clin Infect Dis       Date:  2003-08-15       Impact factor: 9.079

5.  Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial.

Authors:  Ashok Balasubramanyam; Ivonne Coraza; E O'Brian Smith; Lynne W Scott; Payal Patel; Dinakar Iyer; Addison A Taylor; Thomas P Giordano; Rajagopal V Sekhar; Pamela Clark; Edith Cuevas-Sanchez; Swarna Kamble; Christie M Ballantyne; Henry J Pownall
Journal:  J Clin Endocrinol Metab       Date:  2011-05-11       Impact factor: 5.958

Review 6.  The effects of exercise training on metabolic and morphological outcomes for people living with HIV: a systematic review of randomised controlled trials.

Authors:  S Fillipas; C L Cherry; F Cicuttini; L Smirneos; A E Holland
Journal:  HIV Clin Trials       Date:  2010 Sep-Oct

7.  Major lipids, apolipoproteins, and risk of vascular disease.

Authors:  Emanuele Di Angelantonio; Nadeem Sarwar; Philip Perry; Stephen Kaptoge; Kausik K Ray; Alexander Thompson; Angela M Wood; Sarah Lewington; Naveed Sattar; Chris J Packard; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-11-11       Impact factor: 56.272

8.  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.

Authors:  Virginia A Triant; Hang Lee; Colleen Hadigan; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2007-04-24       Impact factor: 5.958

9.  Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection.

Authors:  Michael J Silverberg; Wendy Leyden; Leo Hurley; Alan S Go; Charles P Quesenberry; Daniel Klein; Michael A Horberg
Journal:  Ann Intern Med       Date:  2009-03-03       Impact factor: 25.391

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.